
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current VTRS market cap is 10.33B. The company's latest EPS is USD -0.5404 and P/E is -16.82.
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 3.66B | 3.8B | 3.75B | 3.53B | 3.33B |
Operating Income | 203.9M | -239.9M | 225.9M | -178.1M | -2.88B |
Net Income | 113.9M | -326.4M | 94.8M | -516.5M | -3.04B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 11.95B | 17.89B | 16.26B | 15.43B | 14.74B |
Operating Income | -259.2M | -95.9M | 1.61B | 766.2M | 10.1M |
Net Income | -669.9M | -1.27B | 2.08B | 54.7M | -634.2M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 47.34B | 45.33B | 44.75B | 41.5B | 38.47B |
Total Liabilities | 27.33B | 25.81B | 24.96B | 22.87B | 22.82B |
Total Equity | 20.01B | 19.52B | 19.79B | 18.64B | 15.65B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 61.55B | 54.84B | 50.02B | 47.69B | 41.5B |
Total Liabilities | 38.6B | 34.35B | 28.95B | 27.22B | 22.87B |
Total Equity | 22.95B | 20.49B | 21.07B | 20.47B | 18.64B |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 614.6M | 993.7M | 1.82B | 2.3B | 535.5M |
Investing | -154.3M | 221.5M | 1.97B | 1.8B | -65.1M |
Financing | -425.6M | -1.27B | -2.91B | -4.33B | -467M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 1.23B | 3.02B | 2.95B | 2.8B | 2.3B |
Investing | -301.1M | -117.8M | 1.52B | -764.1M | 1.8B |
Financing | -605.7M | -3.01B | -3.88B | -2.3B | -4.33B |
Market Cap | 10.33B |
Price to Earnings Ratio | -16.82 |
Price to Sales Ratio | 0.72 |
Price to Cash Ratio | 14.52 |
Price to Book Ratio | 0.57 |
Dividend Yield | 5.45% |
Shares Outstanding | 1.17B |
Average Volume (1 week) | 11.75M |
Average Volume (1 Month) | 16.86M |
52 Week Change | -16.11% |
52 Week High | 13.55 |
52 Week Low | 6.85 |
Spread (Intraday) | 0.17 (1.88%) |
Company Name | Viatris Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.viatris.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions